# Partillion Bioscience Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/partillion-bioscience

- Industry: Biotechnology
- Headquarters: Los Angeles, US
- Website: www.partillion.com
- Total disclosed funding: $5M
- Latest round: Seed (Sep 26, 2023)
- Investors on record: 3

## About

Based in California, US, and founded in 2020, Partillion Bioscience Corporation manufactures biotinylated nanovials for use in single-cell secretion experiments. In September 2023, Partillion Bioscience Corporation raised USD 5 million in seed funding from +ND Capital, Paladin Capital Group, and Vertical Venture Partners.

Partillion Bioscience is a life science company that develops tools for single-cell biology research. The firm's nanovial technology allows researchers to analyze and sort single cells based on secreted proteins using existing instruments. This can be used to study a range of biological processes, including antibody production, cell therapy, and cancer immunotherapy.

The company plans to use the September 2023 funding to speed up its growth and support the launch of new products.

## Funding rounds

- Seed, Sep 26, 2023, $5M — Paladin Capital Group, +ND Capital, Vertical Venture Partners

## Investors

- Paladin Capital Group (https://capitalatlas.ai/funds/paladin-capital-group) — Seed
- +ND Capital (https://capitalatlas.ai/funds/nd-capital) — Seed
- Vertical Venture Partners (https://capitalatlas.ai/funds/vertical-venture-partners) — Seed